| Revenue Information |
Note 9 – Revenue Information
Revenue by product lines was as follows:
| |
|
Three Months Ended |
|
|
Six Months Ended |
|
| |
|
June 30, |
|
|
June 30, |
|
| Product Line |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| MicroParticle Catalyzed Biosensor (“MPC”) |
|
$ |
- |
|
|
$ |
65,344 |
|
|
$ |
- |
|
|
$ |
88,664 |
|
| Particle ImmunoFiltration Assay (“PIFA”) |
|
|
(3,399 |
) |
|
|
304,658 |
|
|
|
351,059 |
|
|
|
880,973 |
|
| Rapid Enzymatic Assay (“REA”) |
|
|
- |
|
|
|
85,000 |
|
|
|
- |
|
|
|
85,000 |
|
| Other |
|
|
1,511 |
|
|
|
9,511 |
|
|
|
10,568 |
|
|
|
21,997 |
|
| Total Revenue |
|
$ |
(1,888 |
) |
|
$ |
464,513 |
|
|
$ |
361,627 |
|
|
$ |
1,076,634 |
|
The total revenue by geographic area determined
based on the location of the customers was as follows:
| |
|
Three Months Ended |
|
|
Six Months Ended |
|
| |
|
June 30, |
|
|
June 30, |
|
| Geographic Region |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| United States |
|
$ |
(1,888 |
) |
|
$ |
447,013 |
|
|
$ |
361,627 |
|
|
$ |
1,059,134 |
|
| Rest of World |
|
|
- |
|
|
|
17,500 |
|
|
|
- |
|
|
|
17,500 |
|
| Total Revenue |
|
$ |
(1,888 |
) |
|
$ |
464,513 |
|
|
$ |
361,627 |
|
|
$ |
1,076,634 |
|
The Company had long-lived assets totaling
$0 and $9,823 located in the People’s Republic of China and $4,783 and $194,174 located in the United States as of June 30,
2020 and December 31, 2019, respectively.
|